company background image
4911

G&E Herbal Biotechnology TPEX:4911 Stock Report

Last Price

NT$62.10

Market Cap

NT$3.5b

7D

2.6%

1Y

155.0%

Updated

28 Sep, 2022

Data

Company Financials
4911 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

4911 Stock Overview

G&E Herbal Biotechnology Co., Ltd., a biotechnology company, focuses on the development and commercialization of novel botanical extraction technology and products in Taiwan.

G&E Herbal Biotechnology Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for G&E Herbal Biotechnology
Historical stock prices
Current Share PriceNT$62.10
52 Week HighNT$72.20
52 Week LowNT$22.50
Beta0.30
1 Month Change14.15%
3 Month Change8.76%
1 Year Change155.03%
3 Year Change41.62%
5 Year Change30.60%
Change since IPO16.38%

Recent News & Updates

Apr 20
G&E Herbal Biotechnology (GTSM:4911) Is In A Strong Position To Grow Its Business

G&E Herbal Biotechnology (GTSM:4911) Is In A Strong Position To Grow Its Business

We can readily understand why investors are attracted to unprofitable companies. For example, although...

Shareholder Returns

4911TW Personal ProductsTW Market
7D2.6%-8.2%-7.0%
1Y155.0%-8.5%-19.7%

Return vs Industry: 4911 exceeded the TW Personal Products industry which returned -6.3% over the past year.

Return vs Market: 4911 exceeded the TW Market which returned -19% over the past year.

Price Volatility

Is 4911's price volatile compared to industry and market?
4911 volatility
4911 Average Weekly Movement12.4%
Personal Products Industry Average Movement5.8%
Market Average Movement5.1%
10% most volatile stocks in TW Market8.3%
10% least volatile stocks in TW Market2.5%

Stable Share Price: 4911 is more volatile than 90% of TW stocks over the past 3 months, typically moving +/- 12% a week.

Volatility Over Time: 4911's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of TW stocks.

About the Company

FoundedEmployeesCEOWebsite
200230n/ahttps://www.geherbs.com.tw

G&E Herbal Biotechnology Co., Ltd., a biotechnology company, focuses on the development and commercialization of novel botanical extraction technology and products in Taiwan. It offers hepato protective agent capsules for the treatment of chronic liver inflammation, cirrhosis, hepatitis, and other liver diseases; botanical anti-aging cosmetic products, such as foam cleanser, botanical extract toner, moisture conditioning cream, and whitening clear cream; and SR-100 skin repair gel. The company also provides botanical healthcare products comprising ArthrEnergy, Jujubes Polysaccharide, Diabecut, HepatoClean, Astragali Radix, Goji, Prosta, and SR-100 capsules; and adult products.

G&E Herbal Biotechnology Co., Ltd. Fundamentals Summary

How do G&E Herbal Biotechnology's earnings and revenue compare to its market cap?
4911 fundamental statistics
Market CapNT$3.46b
Earnings (TTM)-NT$19.83m
Revenue (TTM)NT$27.62m

125.2x

P/S Ratio

-174.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
4911 income statement (TTM)
RevenueNT$27.62m
Cost of RevenueNT$20.60m
Gross ProfitNT$7.02m
Other ExpensesNT$26.85m
Earnings-NT$19.83m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.36
Gross Margin25.41%
Net Profit Margin-71.80%
Debt/Equity Ratio0.0%

How did 4911 perform over the long term?

See historical performance and comparison